92.54
                                            
            Vaneck Pharmaceutical Etf stock is traded at $92.54, with a volume of 426.98K.
            It is up +0.21% in the last 24 hours and up +2.41% over the past month.
            
        
        See More
    Previous Close:
              $92.35
            Open:
              $91.74
            24h Volume:
                426.98K
            Relative Volume:
              0.79
            Market Cap:
                $907.13M
            Revenue:
              -
            Net Income/Loss:
              -
            P/E Ratio:
              -
            EPS:
                -
            Net Cash Flow:
                -
            1W Performance:
              +0.12%
            1M Performance:
              +2.41%
            6M Performance:
                +3.44%
            1Y Performance:
              +1.35%
            Vaneck Pharmaceutical Etf Stock (PPH) Company Profile
Name
                  
                      Vaneck Pharmaceutical Etf
                    
                Sector
                  Industry
                  Phone
                  
                      -
                    
                Address
                  
                      -
                    
                Compare PPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS | 
|---|---|---|---|---|---|---|
|   
                          
                                PPH
                            
                             Vaneck Pharmaceutical Etf | 92.54 | 907.13M | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VTI
                            
                             Vanguard Total Stock Market Etf | 335.42 | 417.53B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                SPY
                            
                             Spdr S P 500 Etf Trust | 682.06 | 372.57B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                IVV
                            
                             Ishares Core S P 500 Etf | 685.23 | 253.41B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                VB
                            
                             Vanguard Small Cap Etf | 254.99 | 160.59B | 0 | 0 | 0 | 0.00 | 
|   
                          
                                QQQ
                            
                             Invesco Qqq Trust Series 1 | 629.07 | 124.43B | 0 | 0 | 0 | 0.00 | 
Vaneck Pharmaceutical Etf Stock (PPH) Latest News
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
PPH: The Big Pharma ETF (NASDAQ:PPH) - Seeking Alpha
Is VanEck Pharmaceutical (PPH) the Best Healthcare ETF to Buy? - Insider Monkey
Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? - sharewise.com
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - MSN
4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio - The Globe and Mail
Pharmaceutical ETF on track for best week since 2020 - MarketWatch
VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume Following Dividend Announcement - Defense World
Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End - MSN
Headlines Boost Pharma Stocks. What the Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Say - Barron's
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - inkl
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms - Benzinga
Big Pharma rebounds despite Trump’s latest tariff threat - Seeking Alpha
Biopharma Stocks Rally After Trump Threatens 100% Pharmaceuticals Tariff - inkl
President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio - Seeking Alpha
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit - The Globe and Mail
PPH: Excellent Pharmaceutical ETF, But Bad Timing To Invest (NASDAQ:PPH) - Seeking Alpha
How Trump's Drug Pricing Policies Could Trigger An Epic Pharma Collapse - Seeking Alpha
Belpointe Asset Management LLC Takes $528,000 Position in VanEck Pharmaceutical ETF $PPH - Defense World
Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? - sharewise.com
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing - Benzinga
Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? - sharewise.com
Pharma stocks higher as Trump backs down from 250% tariff threat - Seeking Alpha
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - The Globe and Mail
LPL Financial LLC Cuts Position in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
4. SPDR S&P Pharmaceuticals ETF (ARCA:XPH) - Investing News Network
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - The Globe and Mail
Markets Shrug as Chip and Pharma Stocks Navigate Trump's New Tariff Blitz - Money Morning
Envestnet Asset Management Inc. Reduces Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Cetera Investment Advisers Has $3.16 Million Stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) - Defense World
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
J&J leads big pharma higher after earnings despite Trump’s latest tariff threat - MSN
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - MSN
ETFs To Gain On JNJ's Solid Q1 Earnings & Upbeat Outlook - Barchart.com
Vaneck Pharmaceutical Etf Stock (PPH) Financials Data
        There is no financial data for Vaneck Pharmaceutical Etf (PPH). Check out other stocks for more information.
    
Revenue
Net Income
Cash Flow
EPS
        Open in Yahoo
        |
        Open in Google
            |
            Open in Finviz
        |
        Open in MarketWatch
            |
            Open in EDGAR    
        |
        Open in Reuters
    
    
                Cap:
                 
                  | 
                Volume (24h):
                 
            
         
                     
                             Get the Stockscreener App
                    Get the Stockscreener App